# FDA Inspection 681751 - Pfizer Pharmaceuticals LLC-Piperacillin - September 15, 2010

Source: https://www.keypedia.com/records/fda_inspections/pfizer-pharmaceuticals-llc-piperacillin/e392e64f-07e5-477a-b95a-c678d9e14884
Source feed: FDA_Inspections

> FDA Inspection 681751 for Pfizer Pharmaceuticals LLC-Piperacillin on September 15, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 681751
- Company Name: Pfizer Pharmaceuticals LLC-Piperacillin
- Inspection Date: 2010-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 766147 - 2012-02-03](https://www.keypedia.com/records/fda_inspections/pfizer-pharmaceuticals-llc-piperacillin/1da439ce-55f3-4408-8d39-a42325ef13a0)
- [FDA Inspection 602563 - 2009-08-07](https://www.keypedia.com/records/fda_inspections/pfizer-pharmaceuticals-llc-piperacillin/6fcb72fc-3d32-431d-bfde-f1f17dc1e571)
- [FDA Inspection 602563 - 2009-08-07](https://www.keypedia.com/records/fda_inspections/pfizer-pharmaceuticals-llc-piperacillin/6f68ebb6-3062-4682-ab08-5629d9c3b566)

Company: https://www.keypedia.com/companies/pfizer-pharmaceuticals-llc-piperacillin/bea0698b-5ee7-4823-838c-5e8383b2aa40

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c